Heron Therapeutics IncNASDAQ:HRTX
- LAST PRICE1.7400
- TODAY'S CHANGE (%)-0.0600 (-3.3333%)
- Bid / Lots1.7200/ 20
- Ask / Lots1.7900/ 5
- Open / Previous Close1.8000 / 1.8000
- Day Range
- 52 Week Range
- Volume1,199,453
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HRTX |
|---|---|---|
| 09:32 ET | 3909 | 1.805 |
| 09:34 ET | 3480 | 1.78 |
| 09:36 ET | 500 | 1.775 |
| 09:38 ET | 1300 | 1.775 |
| 09:39 ET | 2000 | 1.775 |
| 09:41 ET | 1638 | 1.76 |
| 09:43 ET | 19290 | 1.7393 |
| 09:45 ET | 1474 | 1.73 |
| 09:48 ET | 1975 | 1.735 |
| 09:50 ET | 5558 | 1.7279 |
| 09:52 ET | 500 | 1.7288 |
| 09:54 ET | 700 | 1.72 |
| 09:56 ET | 1800 | 1.725 |
| 09:57 ET | 18595 | 1.71 |
| 09:59 ET | 995 | 1.71 |
| 10:01 ET | 14644 | 1.7091 |
| 10:03 ET | 16153 | 1.705 |
| 10:06 ET | 14012 | 1.71 |
| 10:08 ET | 100 | 1.715 |
| 10:10 ET | 3909 | 1.715 |
| 10:12 ET | 2350 | 1.72 |
| 10:14 ET | 5995 | 1.725 |
| 10:15 ET | 72619 | 1.725 |
| 10:19 ET | 632 | 1.73 |
| 10:21 ET | 4100 | 1.72 |
| 10:24 ET | 6432 | 1.74 |
| 10:26 ET | 707 | 1.735 |
| 10:28 ET | 4740 | 1.725 |
| 10:30 ET | 1700 | 1.725 |
| 10:32 ET | 1050 | 1.725 |
| 10:33 ET | 100 | 1.725 |
| 10:35 ET | 1556 | 1.72 |
| 10:37 ET | 56297 | 1.74 |
| 10:39 ET | 3500 | 1.735 |
| 10:42 ET | 4169 | 1.72 |
| 10:44 ET | 3208 | 1.72 |
| 10:46 ET | 3270 | 1.7188 |
| 10:48 ET | 2300 | 1.71 |
| 10:50 ET | 723 | 1.71 |
| 10:51 ET | 300 | 1.71 |
| 10:53 ET | 700 | 1.71 |
| 10:55 ET | 100 | 1.71 |
| 10:57 ET | 600 | 1.715 |
| 11:00 ET | 300 | 1.71 |
| 11:02 ET | 1348 | 1.71 |
| 11:04 ET | 19364 | 1.715 |
| 11:06 ET | 600 | 1.72 |
| 11:08 ET | 700 | 1.71 |
| 11:09 ET | 6065 | 1.7251 |
| 11:11 ET | 19241 | 1.7243 |
| 11:13 ET | 400 | 1.72 |
| 11:15 ET | 11338 | 1.725 |
| 11:18 ET | 600 | 1.73 |
| 11:20 ET | 700 | 1.7299 |
| 11:22 ET | 800 | 1.72 |
| 11:24 ET | 700 | 1.73 |
| 11:26 ET | 17793 | 1.73 |
| 11:27 ET | 3128 | 1.725 |
| 11:29 ET | 600 | 1.725 |
| 11:31 ET | 800 | 1.72 |
| 11:33 ET | 10759 | 1.73 |
| 11:36 ET | 300 | 1.73 |
| 11:38 ET | 309 | 1.74 |
| 11:40 ET | 1000 | 1.735 |
| 11:42 ET | 2000 | 1.74 |
| 11:44 ET | 7058 | 1.75 |
| 11:45 ET | 300 | 1.745 |
| 11:47 ET | 5800 | 1.74 |
| 11:49 ET | 2579 | 1.735 |
| 11:51 ET | 100 | 1.73 |
| 11:54 ET | 8163 | 1.735 |
| 11:56 ET | 300 | 1.73 |
| 11:58 ET | 2965 | 1.73 |
| 12:00 ET | 2138 | 1.735 |
| 12:02 ET | 7771 | 1.735 |
| 12:03 ET | 100 | 1.735 |
| 12:05 ET | 300 | 1.735 |
| 12:07 ET | 1771 | 1.74 |
| 12:09 ET | 13489 | 1.74 |
| 12:12 ET | 7876 | 1.735 |
| 12:14 ET | 2371 | 1.735 |
| 12:16 ET | 1600 | 1.74 |
| 12:20 ET | 5849 | 1.745 |
| 12:21 ET | 7018 | 1.745 |
| 12:23 ET | 1125 | 1.745 |
| 12:25 ET | 1400 | 1.745 |
| 12:27 ET | 4300 | 1.74 |
| 12:30 ET | 1400 | 1.74 |
| 12:32 ET | 8400 | 1.745 |
| 12:34 ET | 600 | 1.745 |
| 12:36 ET | 800 | 1.745 |
| 12:38 ET | 1029 | 1.74 |
| 12:39 ET | 500 | 1.74 |
| 12:41 ET | 3657 | 1.75 |
| 12:43 ET | 4692 | 1.74 |
| 12:45 ET | 500 | 1.74 |
| 12:48 ET | 5191 | 1.735 |
| 12:50 ET | 800 | 1.735 |
| 12:52 ET | 300 | 1.73 |
| 12:54 ET | 200 | 1.73 |
| 12:56 ET | 807 | 1.735 |
| 12:57 ET | 14317 | 1.735 |
| 12:59 ET | 700 | 1.74 |
| 01:01 ET | 500 | 1.735 |
| 01:03 ET | 1400 | 1.735 |
| 01:06 ET | 300 | 1.735 |
| 01:08 ET | 200 | 1.74 |
| 01:10 ET | 100 | 1.74 |
| 01:12 ET | 229 | 1.74 |
| 01:14 ET | 216 | 1.735 |
| 01:15 ET | 200 | 1.735 |
| 01:17 ET | 362 | 1.7399 |
| 01:19 ET | 200 | 1.74 |
| 01:21 ET | 14819 | 1.74 |
| 01:24 ET | 2829 | 1.745 |
| 01:26 ET | 300 | 1.75 |
| 01:28 ET | 815 | 1.74 |
| 01:30 ET | 7576 | 1.735 |
| 01:32 ET | 100 | 1.735 |
| 01:33 ET | 500 | 1.73 |
| 01:35 ET | 814 | 1.73 |
| 01:37 ET | 2300 | 1.73 |
| 01:39 ET | 388 | 1.7349 |
| 01:42 ET | 1450 | 1.73 |
| 01:44 ET | 10610 | 1.729 |
| 01:46 ET | 369 | 1.7201 |
| 01:48 ET | 550 | 1.7278 |
| 01:50 ET | 2325 | 1.73 |
| 01:51 ET | 15514 | 1.735 |
| 01:53 ET | 494 | 1.735 |
| 01:55 ET | 250 | 1.735 |
| 01:57 ET | 408 | 1.735 |
| 02:00 ET | 712 | 1.735 |
| 02:02 ET | 2766 | 1.735 |
| 02:04 ET | 504 | 1.735 |
| 02:06 ET | 803 | 1.735 |
| 02:08 ET | 2768 | 1.735 |
| 02:09 ET | 379 | 1.735 |
| 02:11 ET | 813 | 1.735 |
| 02:13 ET | 4081 | 1.735 |
| 02:15 ET | 1221 | 1.735 |
| 02:18 ET | 904 | 1.735 |
| 02:20 ET | 609 | 1.735 |
| 02:22 ET | 508 | 1.73 |
| 02:24 ET | 16531 | 1.725 |
| 02:26 ET | 512 | 1.725 |
| 02:27 ET | 1703 | 1.725 |
| 02:29 ET | 740 | 1.725 |
| 02:31 ET | 6993 | 1.725 |
| 02:33 ET | 900 | 1.72 |
| 02:36 ET | 900 | 1.725 |
| 02:38 ET | 8862 | 1.725 |
| 02:40 ET | 387 | 1.725 |
| 02:42 ET | 2958 | 1.725 |
| 02:44 ET | 489 | 1.725 |
| 02:45 ET | 14826 | 1.72 |
| 02:47 ET | 1205 | 1.73 |
| 02:49 ET | 3400 | 1.725 |
| 02:51 ET | 512 | 1.725 |
| 02:54 ET | 1569 | 1.725 |
| 02:56 ET | 6704 | 1.725 |
| 02:58 ET | 11640 | 1.725 |
| 03:00 ET | 455 | 1.725 |
| 03:02 ET | 6016 | 1.725 |
| 03:03 ET | 431 | 1.725 |
| 03:05 ET | 28838 | 1.735 |
| 03:07 ET | 200 | 1.74 |
| 03:09 ET | 11212 | 1.75 |
| 03:12 ET | 16265 | 1.745 |
| 03:14 ET | 1131 | 1.75 |
| 03:16 ET | 16319 | 1.745 |
| 03:18 ET | 2193 | 1.745 |
| 03:20 ET | 5839 | 1.745 |
| 03:21 ET | 3499 | 1.745 |
| 03:23 ET | 1078 | 1.745 |
| 03:25 ET | 10266 | 1.745 |
| 03:27 ET | 17679 | 1.745 |
| 03:30 ET | 3825 | 1.74 |
| 03:32 ET | 100 | 1.74 |
| 03:34 ET | 700 | 1.745 |
| 03:36 ET | 69113 | 1.745 |
| 03:38 ET | 2478 | 1.745 |
| 03:39 ET | 4259 | 1.75 |
| 03:41 ET | 5367 | 1.74 |
| 03:43 ET | 1322 | 1.74 |
| 03:45 ET | 39421 | 1.755 |
| 03:48 ET | 2199 | 1.755 |
| 03:50 ET | 13866 | 1.755 |
| 03:52 ET | 13527 | 1.755 |
| 03:54 ET | 25358 | 1.755 |
| 03:56 ET | 3167 | 1.755 |
| 03:57 ET | 36300 | 1.745 |
| 03:59 ET | 107754 | 1.74 |
Oct 29, 2024
Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024, from 4:05PM ET on Tuesday Oct 29, 2024 by Dow Jones
4:05PM ET on Tuesday Oct 29, 2024 by Dow Jones
Oct 10, 2024
DJ Heron Therapeutics Reaffirms Treatment Supply After Hurricane Helene, from 5:06PM ET on Thursday Oct 10, 2024 by Dow Jones
5:06PM ET on Thursday Oct 10, 2024 by Dow Jones*DJ Heron Therapeutics: Reaffirms Availability and Ample Supply of CINVANTI, SUSTOL, APONVIE as Alternatives During Potential Shortage of Intravenous Fluids, from 4:30PM ET on Thursday Oct 10, 2024 by Dow Jones
4:30PM ET on Thursday Oct 10, 2024 by Dow JonesHeron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI(R), SUSTOL(R), and APONVIE(R) as Alternatives During the Potential Shortage of Intravenous Fluids, from 4:08PM ET on Thursday Oct 10, 2024 by Dow Jones
4:08PM ET on Thursday Oct 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Heron Therapeutics Inc | 273.0M | -5.4x | --- |
Seres Therapeutics Inc | 133.2M | -0.7x | --- |
Kamada Ltd | 322.0M | 19.4x | -22.48% |
Sutro Biopharma Inc | 291.8M | -1.8x | --- |
2Seventy Bio Inc | 235.9M | -1.4x | --- |
Chromadex Corp | 271.8M | -193.9x | --- |
Company Information
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous (IV) formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist. Its acute care product portfolio includes ZYNRELEF and APONVIE. HTX- ZYNRELEF is a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam. APONVIE is the IV formulation of a NK1 receptor antagonist indicated for postoperative nausea and vomiting (PONV). Its products are distributed in the United States.
Contact Information
- Headquarters
- 4242 Campus Point Court, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-251-4400
- Fax
- ---
Executives
- Chairman of the Board
- Adam Morgan
- Chief Executive Officer, Director
- Craig Collard
- Chief Financial Officer, Principal Accounting Officer
- Ira Duarte
- Executive Vice President, Chief Development Officer
- William Forbes
- Vice President
- Lisa Peraza
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $273.0M |
|---|---|
Revenue (TTM) | $136.4M |
Shares Outstanding | 151.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.80 |
EPS | $-0.32 |
Book Value | $-0.23 |
P/E Ratio | -5.4x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
